Brief: Living Cell Technologies Undertakes A$2.5 Mln Capital Raise Initiative
March 1 (Reuters) - Living Cell Technologies Ltd
LCT.AX :
* LCT UNDERTAKES A$2.5 MILLION CAPITAL RAISE INITIATIVE
* ALSO INTENDS TO COMPLETE A NON-RENOUNCEABLE RIGHTS ISSUE
ENTITLEMENT OFFER
* RIGHTS ISSUE OFFER AT ONE NEW SHARE IN CO FOR EVERY EIGHT
SHARES
HELD
Source text for Eikon: ID:nASXVKhB8
Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative